Active Pharmaceutical Ingredients

Home > Products > Active Pharmaceutical Ingredients > Pemetrexed Disodium

Pemetrexed Disodium

Pemetrexed Disodium

Indication: This product is combined with cisplatin for the treatment of inoperable malignant pleural mesothelioma.

Inquire Now Next Product

Overview

Specification: USP/CP

CAS NO.: 150399-23-8

Molecular formula: C20H22N5NaO6

Structural Formula:

Pemetrexed Disodium

For high value products, please select air shipping and DHL express for safe.

FAQ

Q: Do you provide samples? Is it free or extra?

A:Yes, we could offer the sample for free charge but do not pay the cost of freight.

Q: Are you trading company or manufacturer?

A:We are factory with certain scale. So no intermediate charge needed. You can get more favorable price, and we can assure the stable stock.

Q: Do you provide certificate?

A:All tests required for export are provided.

Q: Can you accept customization?

A:Yes, we offer OEM/ODM service. You can custom every similar product you want.

Related Products

All Products

Latest News

Deepen Cultivation of Big Health, and Struggle for New Chapter

Deepen Cultivation of Big Health, and Struggle for New Chapter Jan. 03, 2023

Fight Against The COVID-19, Make Concerted Efforts

Fight Against The COVID-19, Make Concerted Efforts Apr. 11, 2022

Our Newsletter

+86 177 9999 8088

Zhendong Science and Technology Park, Changzhi City, Shanxi Province

wujiaming@zdjt.com

ABOUT ZHENGDONG

Overview Certificates Group Influence News

R&D

Zhendong Pharmaceuticals Co. ltd. signed the contract with AG Research Co.，LTD from the U.S.Zark Howard, an oncologist from US National Cancer Center, and her accompanies visited the herb planting base.Zhendong Pharmaceutical and oncology experts of US, England, and Australia cofound“International Chinese Medicine Treatment Cancer Alliance Preparatory Committee”.Bruce Ullrich, Board director of Massey University of New Zealand, visited Zhendong for key collaboration on functional health-food.Zhendong signed the second phase of the strategic collaboration agreement with China-Australia molecular research center of Adelaide University of Australia.

Products

Pharmaceutical Preparations Herb Raw Materials Traditional Chinese Medicine Active Pharmaceutical Ingredients

LATEST NEWS

Deepen Cultivation of Big Health, and Struggle for New Chapter

Deepen Cultivation of Big Health, and Struggle for New Chapter Jan. 03, 2023

Fight Against The COVID-19, Make Concerted Efforts

Fight Against The COVID-19, Make Concerted Efforts Apr. 11, 2022

Keywords: Traditional Chinese Medicinal Materials

Copyright © Zhendong Industrial Group Co., Ltd. All Rights Reserved | Sitemap | Technical Support: